Lack of Economic Benefit with Basiliximab Induction in Living Related Donor Adult Renal Transplant Recipients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lack of Economic Benefit with Basiliximab Induction in Living Related Donor Adult Renal Transplant Recipients

Published:2003-04 Issue:4 Volume:23 Page:443-450
ISSN:0277-0008
Container-title:Pharmacotherapy
language:en
Short-container-title:Pharmacotherapy

Author:

Crompton Jason A.,Somerville Troy,Smith Lonnie,Corbett Jacke,Nelson Edward,Holman John,Shihab Fuad S.

Publisher

Wiley

Subject

Pharmacology (medical)

Reference26 articles.

1. Quality of life in end-stage renal disease patients

3. A Review of Quality of Life in Chronic Renal Failure

4. A study of the quality of life and cost-utility of renal transplantation

5. Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric Transplant

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of induction therapy in low-immunological risk kidney transplant recipients regardless of HLA matching;Transplant Immunology;2023-02

2. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model;Health Technology Assessment;2016-08

3. Basiliximab;Meyler's Side Effects of Drugs;2016

4. Induction Immunosuppressive Therapy in Kidney Transplantation;Experimental and Clinical Transplantation;2014-03

5. Basiliximab: efficacy and safety evaluation in kidney transplantation;Expert Opinion on Drug Safety;2013-11-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP